D. Gareth Evans

134.4k total citations · 21 hit papers
1.2k papers, 57.6k citations indexed

About

D. Gareth Evans is a scholar working on Genetics, Oncology and Neurology. According to data from OpenAlex, D. Gareth Evans has authored 1.2k papers receiving a total of 57.6k indexed citations (citations by other indexed papers that have themselves been cited), including 393 papers in Genetics, 290 papers in Oncology and 221 papers in Neurology. Recurrent topics in D. Gareth Evans's work include BRCA gene mutations in cancer (316 papers), Neurofibromatosis and Schwannoma Cases (215 papers) and Meningioma and schwannoma management (155 papers). D. Gareth Evans is often cited by papers focused on BRCA gene mutations in cancer (316 papers), Neurofibromatosis and Schwannoma Cases (215 papers) and Meningioma and schwannoma management (155 papers). D. Gareth Evans collaborates with scholars based in United Kingdom, United States and Germany. D. Gareth Evans's co-authors include Doyle J. Evans, David Y. Graham, Anthony Howell, David J. Evans, Fiona Lalloo, Susan Huson, Jillian M. Birch, Diana Eccles, Herbert L. DuPont and Peter Klein and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

D. Gareth Evans

1.1k papers receiving 54.7k citations

Hit Papers

Prophylactic Oophorectomy... 1975 2026 1992 2009 2002 2002 2010 2004 1991 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prophylactic Oophorectomy in Carriers ofBRCA1orBRCA2Mutations
    2002 1.0k citations Timothy R. Rebbeck, Henry T. Lynch et al. profile →
  2. Malignant peripheral nerve sheath tumours in neurofibromatosis 1
    2002 834 citations D. Gareth Evans et al. Journal of Medical Genetics profile →
  3. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)
    2010 816 citations Malcolm G. Dunlop, D. Gareth Evans et al. Gut profile →
  4. Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group
    2004 812 citations Timothy R. Rebbeck, Tara M. Friebel et al. Journal of Clinical Oncology profile →
  5. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States
    1991 786 citations D. Gareth Evans et al. profile →
  6. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)
    2005 765 citations Caroline Boggis, Douglas F. Easton et al. profile →
  7. Preparation of Fe3O4@SiO2@Layered Double Hydroxide Core–Shell Microspheres for Magnetic Separation of Proteins
    2011 731 citations D. Gareth Evans et al. profile →
  8. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
    2006 689 citations D. Gareth Evans, Diana Eccles et al. profile →
  9. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1
    2006 652 citations D. Gareth Evans et al. Journal of Medical Genetics profile →
  10. Birth incidence and prevalence of tumor‐prone syndromes: Estimates from a UK family genetic register service
    2010 643 citations D. Gareth Evans, Fiona Lalloo et al. profile →
  11. Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans
    1975 605 citations D. Gareth Evans et al. profile →
  12. Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk
    2015 579 citations Douglas F. Easton, D. Gareth Evans et al. profile →
  13. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women
    2010 577 citations Michelle Harvie, Mary Pegington et al. profile →
  14. Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles
    2006 513 citations D. Gareth Evans, Diana Eccles et al. profile →
  15. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles
    2006 511 citations D. Gareth Evans, Diana Eccles et al. profile →
  16. Hemagglutination of Human Group A Erythrocytes by Enterotoxigenic Escherichia coli Isolated from Adults with Diarrhea: Correlation with Colonization Factor
    1977 485 citations D. Gareth Evans et al. profile →
  17. A Clinical Study of Type 2 Neurofibromatosis
    1992 475 citations D. Gareth Evans et al. profile →
  18. Factors influencing the eradication of Helicobacter pylori with triple therapy
    1992 455 citations D. Gareth Evans et al. profile →
  19. New Surface-Associated Heat-Labile Colonization Factor Antigen (CFA/II) Produced by Enterotoxigenic Escherichia coli of Serogroups O6 and O8
    1978 358 citations D. Gareth Evans et al. profile →
  20. EANO guideline on the diagnosis and treatment of vestibular schwannoma
    2019 230 citations D. Gareth Evans et al. profile →
  21. Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline
    2022 98 citations Susan M. Domchek, D. Gareth Evans et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
D. Gareth Evans 16.9k 12.4k 11.1k 10.6k 9.0k 1.2k 57.6k
Giuseppe Remuzzi 4.3k 0.3× 16.0k 1.3× 4.6k 0.4× 1.6k 0.1× 12.4k 1.4× 1.3k 95.1k
Francis S. Collins 13.2k 0.8× 30.8k 2.5× 6.9k 0.6× 4.8k 0.5× 3.4k 0.4× 423 60.9k
Tak W. Mak 5.8k 0.3× 49.6k 4.0× 22.6k 2.0× 2.5k 0.2× 3.9k 0.4× 710 96.1k
Jin Li 14.8k 0.9× 29.3k 2.4× 5.3k 0.5× 1.9k 0.2× 3.8k 0.4× 2.6k 73.4k
Douglas R. Green 5.1k 0.3× 80.9k 6.5× 18.8k 1.7× 2.1k 0.2× 4.7k 0.5× 613 125.1k
Alberto Mantovani 5.1k 0.3× 42.5k 3.4× 45.1k 4.1× 2.0k 0.2× 11.2k 1.3× 1.1k 157.6k
Harold Varmus 11.8k 0.7× 32.5k 2.6× 13.2k 1.2× 3.7k 0.3× 1.4k 0.2× 407 56.3k
Josef Penninger 3.9k 0.2× 40.9k 3.3× 14.8k 1.3× 4.0k 0.4× 4.9k 0.5× 582 78.3k
Jun Wang 9.5k 0.6× 34.0k 2.7× 3.1k 0.3× 1.2k 0.1× 3.1k 0.3× 1.9k 66.2k
Yehuda Shoenfeld 6.2k 0.4× 8.2k 0.7× 3.0k 0.3× 5.4k 0.5× 6.6k 0.7× 1.6k 63.1k

Countries citing papers authored by D. Gareth Evans

Since Specialization
Citations

This map shows the geographic impact of D. Gareth Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Gareth Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Gareth Evans more than expected).

Fields of papers citing papers by D. Gareth Evans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Gareth Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Gareth Evans. The network helps show where D. Gareth Evans may publish in the future.

Co-authorship network of co-authors of D. Gareth Evans

This figure shows the co-authorship network connecting the top 25 collaborators of D. Gareth Evans. A scholar is included among the top collaborators of D. Gareth Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Gareth Evans. D. Gareth Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harkness, Elaine F., et al.. (2024). Breast density prediction from low and standard dose mammograms using deep learning: effect of image resolution and model training approach on prediction quality. Biomedical Physics & Engineering Express. 10(4). 45021–45021. 1 indexed citations
2.
Pegington, Mary, Rhiannon E Hawkes, Alan Davies, et al.. (2024). An app promoting weight gain prevention via healthy behaviours amongst young women with a family history of breast cancer: Acceptability and usability assessment. Journal of Human Nutrition and Dietetics. 37(5). 1170–1185.
3.
Halliday, Dorothy, et al.. (2023). Updated protocol for genetic testing, screening and clinical management of individuals at risk of NF2 ‐related schwannomatosis. Clinical Genetics. 103(5). 540–552. 6 indexed citations
4.
Crosbie, Emma J., Emma R. Woodward, Fiona Lalloo, et al.. (2023). MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1. Journal of Medical Genetics. 60(6). 576–577. 2 indexed citations
5.
Islim, Abdurrahman I., Cathal John Hannan, Charlotte Hammerbeck-Ward, et al.. (2023). The clinical, genetic, and immune landscape of meningioma in patients with NF2-schwannomatosis. Neuro-Oncology Advances. 5(Supplement_1). i94–i104. 5 indexed citations
6.
Green, Jonathan, Gorana Pobric, JeYoung Jung, et al.. (2022). Neuroanatomical correlates of working memory performance in Neurofibromatosis 1. Cerebral Cortex Communications. 3(2). tgac021–tgac021. 1 indexed citations
7.
Hurson, Amber N., Parichoy Pal Choudhury, Chi Gao, et al.. (2021). Prospective evaluation of a breast-cancer risk model integrating classical risk factors and polygenic risk in 15 cohorts from six countries. International Journal of Epidemiology. 50(6). 1897–1911. 43 indexed citations
8.
Veen, Elke M. van, Olivia Smith, William G. Newman, et al.. (2021). Dominant‐negative pathogenic variant BRIP1 c. 1045G >C is a high‐risk allele for non‐mucinous epithelial ovarian cancer: A case‐control study. Clinical Genetics. 101(1). 48–54. 4 indexed citations
9.
Crosbie, Emma J., et al.. (2019). Epithelial ovarian cancer risk: A review of the current genetic landscape. Clinical Genetics. 97(1). 54–63. 41 indexed citations
10.
Howell, Anthony, Linda Ashcroft, Lesley Fallowfield, et al.. (2017). RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. 27(1). 58–66. 4 indexed citations
11.
Evans, D. Gareth, Adam R. Brentnall, Michelle Harvie, et al.. (2014). Breast Cancer Risk in Young Women in the National Breast Screening Programme: Implications for Applying NICE Guidelines for Additional Screening and Chemoprevention. Cancer Prevention Research. 7(10). 993–1001. 32 indexed citations
12.
Camp, Nicola J., Marina Parry, Stacey Knight, et al.. (2012). Fine-Mapping CASP8 Risk Variants in Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. 21(1). 176–181. 20 indexed citations
13.
Evans, D. Gareth, Jane Warwick, Susan Astley, et al.. (2012). Assessing Individual Breast Cancer Risk within the U.K. National Health Service Breast Screening Program: A New Paradigm for Cancer Prevention. Cancer Prevention Research. 5(7). 943–951. 93 indexed citations
14.
Burn, John, D. Timothy Bishop, Pamela Chapman, et al.. (2011). A Randomized Placebo-Controlled Prevention Trial of Aspirin and/or Resistant Starch in Young People with Familial Adenomatous Polyposis. Cancer Prevention Research. 4(5). 655–665. 151 indexed citations
15.
Newman, William G., Kristen D. Hadfield, Ayşe Latif, et al.. (2008). Impaired Tamoxifen Metabolism Reduces Survival in Familial Breast Cancer Patients. Clinical Cancer Research. 14(18). 5913–5918. 88 indexed citations
16.
Kauff, Noah D., Susan M. Domchek, Tara M. Friebel, et al.. (2008). Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study. Journal of Clinical Oncology. 26(8). 1331–1337. 381 indexed citations
17.
Wallace, Andrew J., et al.. (2004). Mutation Scanning of the NF2 Gene: An Improved Service Based on Meta-PCR/Sequencing, Dosage Analysis, and Loss of Heterozygosity Analysis. Genetic Testing. 8(4). 368–380. 28 indexed citations
18.
Foster, Claire, D. Gareth Evans, Rosalind A. Eeles, et al.. (2004). Non-Uptake of Predictive Genetic Testing for BRCA1/2 among Relatives of Known Carriers: Attributes, Cancer Worry, and Barriers to Testing in a Multicenter Clinical Cohort. Genetic Testing. 8(1). 23–29. 56 indexed citations
19.
Evans, D. Gareth, et al.. (2002). Feeding infants of diabetic mothers. Archives of Disease in Childhood. 87(1). 70–70.
20.
Evans, D. Gareth, et al.. (1996). Oesophagus (clinical). Gut. 38(Suppl 1). A23–A24. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giuseppe Remuzzi Breakdown of academic impact, for papers by Francis S. Collins Breakdown of academic impact, for papers by Tak W. Mak Breakdown of academic impact, for papers by Jin Li Breakdown of academic impact, for papers by Douglas R. Green Breakdown of academic impact, for papers by Alberto Mantovani Breakdown of academic impact, for papers by Harold Varmus Breakdown of academic impact, for papers by Josef Penninger Breakdown of academic impact, for papers by Jun Wang Breakdown of academic impact, for papers by Yehuda Shoenfeld
Rankless by CCL
2026